This ISN webinar will guide participants through approaches to the management of SLE in low and middle income countries (LMIC) with reference to South Africa. This webinar aims to demonstrate that early recognition is important, acute disease requires aggressive immunosuppression, renal biopsy is helpful in management and a multidisciplinary team is probably the best when it comes to SLE management in LMIC.
Description of the Webinar
Systemic Lupus Erythematosus (SLE) is a relatively common condition in SA among females (particularly those with mixed ancestory). Renal involvement occurs in the majority and is the main cause of mortality in patients with SLE. Specific treatment of the nephritis follows world-wide trends. Because of financial constraints, induction therapy for aggressive nephritis, is usually with steroids and IV Cyclophosphamide, while maintenance therapy combines Azathioprine and steriods. The usual anti-proteinuric and blood pressure control measures are used in addition to Chloroquin.
Webinar Webcast:
This webinar took place on Friday, Nov 20th 2015. For those who missed the webinar you can view the webcast below:
Test your knowledge of managing SLE in LMIC with this post-webinar quiz!
About the Facilitator
 |
Professor Charles Swanepoel – Charles Swanepoel is an Emeritus Associate Professor in the Division of Nephrology, Department of Medicine, Groote Schuur Hospital and the University of Cape Town (UCT). He continues with research and teaching at UCT. He serves as a subject Editor for Nephrology and has published in various nephrology journals including, Kidney International, NDT, American Journal of Kidney Diseases and Nature Reviews Nephrology. . |
Additional Info
-
Language:
English -
Contains Audio:
Yes -
Content Type:
Webinars -
Source:
ISN -
Year:
2015 -
Members Only:
No